Injectable Formulations
Comprehensive portfolio of liquid, lyophilized, and ophthalmic formulations for global markets
SIGMAK supports global pharmaceutical partners with a broad portfolio of injectable formulations sourced from WHO-GMP compliant manufacturing facilities, backed by regulatory documentation and dependable supply support across major therapeutic areas.
Product List
Browse our comprehensive range of 386 injectable formulations
| Product Name | Strength | Description | Therapeutic Application | |
|---|---|---|---|---|
Aceclofenac Injection | 50 mg | 1 ml | Analgesic / Anti-inflammatory | |
Aceclofenac Injection | 150 mg | 1 ml | Analgesic / Anti-inflammatory | |
Aciclovir for Injection USP | 250 mg | Vial | Antiviral | |
Acyclovir for Injection USP | 250 mg | Vial | Antibiotic / Anti-infective | |
Acyclovir for Injection USP | 500 mg | Vial | Antibiotic / Anti-infective | |
Adrenaline Injection BP | 1 mg | 1 ml | Cardiovascular | |
Adrenaline Injection IP | 1 mg | 1 ml | Cardiovascular | |
Adrenochrome Monosemicarbazone Injection | 50 mg + 0.5 % w/v | 1 ml | Haemostatic / Emergency Care | |
Adrenochrome Monosemicarbazone Injection | 0.75 mg | 1 ml | Haemostatic / Emergency Care | |
Alfa Beta Arteether Injection | 225 mg | 3 ml | Anti-malarial | |
Amikacin Injection BP | 500 mg | 2 ml | Antibiotic / Anti-infective | |
Amikacin Injection BP | 100 mg | 2 ml | Antibiotic / Anti-infective | |
Amikacin Injection BP | 250 mg | 2 ml | Antibiotic / Anti-infective | |
Amikacin Sulphate Injection BP | 100 mg/2 mL | 2 ml | Antibiotic / Anti-infective | |
Amikacin Sulphate Injection BP | 500 mg/2 mL | 2 ml | Antibiotic / Anti-infective | |
Amikacin Sulphate Injection BP | 1 g/4 mL | 4 ml | Antibiotic / Anti-infective | |
Amikacin Sulphate Injection IP | 500 mg | 2 ml | Antibiotic / Anti-infective | |
Amikacin Sulphate Injection IP | 100 mg | 2 ml | Antibiotic / Anti-infective | |
Amikacin Sulphate Injection IP | 250 mg | 2 ml | Antibiotic / Anti-infective | |
Aminophylline Injection BP | 250 mg | 10 ml | Anti-allergic / Respiratory | |
Aminophylline Injection IP | 25 mg | 1 ml | Anti-allergic / Respiratory | |
Amphotericin B for Injection USP | 50 mg | Vial | Antifungal | |
Artemether Injection | 80 mg | 1 ml | Anti-malarial | |
Artesunate Injection IP | 60 mg | Vial | Anti-malarial | |
Artesunate Injection IP | 120 mg | Vial | Anti-malarial |
Key Capabilities
Injectable Supply & Registration Support
SIGMAK supports pharmaceutical buyers with injectable formulations for international distribution, registration planning, and market expansion across Africa, the Middle East, CIS, Latin America, and Southeast Asia — backed by WHO-GMP aligned sourcing, product documentation, and responsive commercial support for tenders and institutional procurement.
Disclaimer:
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer. Products will not be supplied to countries where patent laws are in force, unless permitted by law or the buyer assumes all responsibility.